RxDoctor Payments DataLook up a doctor →

Seida Velija

Family · Brooklyn, NYNPI 1871987198

Payments from drug & device makers

$62,353in general payments, 2019–2025

Across 771 payments — averaging $80.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$26K
  • Lilly USA, LLC$25K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • AbbVie$1K
  • Johnson & Johnson$1K
  • Gilead$852
  • plus $5K from 21 others

What the payments were for

  • Speaking & faculty fees$36,79859%
  • Travel & lodging$11,14218%
  • Food & beverage$14,26323%
  • Education$1500%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$62,353 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide42$44,092
CreonLipase/Protease/Amylase24$34,444
ZenpepLipase/Protease/Amylase11$14,918
TrulancePlecanatide13$7,891
Dexlansoprazole DrDexlansoprazole12$5,881
Mesalamine11$4,577
Budesonide EcBudesonide12$4,175
Famotidine228$3,180
Omeprazole189$2,200
Pantoprazole Sodium157$2,034
Sucralfate57$1,141
Dicyclomine Hcl35$928
Esomeprazole Magnesium11$567
LoperamideLoperamide Hcl16$526
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine15$488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$1,461$78,53666 claims
Aimmune Therapeutics, Inc.Zenpep$134$14,91811 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$2,022$7,89113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.

Other family in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →